መነሻ › ማይሎዲስፕላስቲክ ሲንድሮሞች
በአሜሪካ ለማይሎዲስፕላስቲክ ሲንድሮሞች ተሳታፊዎችን እየፈለጉ ያሉ ክሊኒካዊ ጥናቶች
ለማይሎዲስፕላስቲክ ሲንድሮሞች የሚደረጉ 157 ጥናቶች በአሜሪካ ውስጥ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በጣም ብዙ ጥናቶች ያሏቸው ከተሞች
- Houston, TX43 ጥናቶች
- Baldwin Park, CA26 ጥናቶች
- New York City, NY21 ጥናቶች
- Seattle, WA21 ጥናቶች
- Washington, DC20 ጥናቶች
- Boston, MA19 ጥናቶች
- Tampa, FL19 ጥናቶች
- Miami, FL17 ጥናቶች
- Columbus, OH14 ጥናቶች
- Durham, NC14 ጥናቶች
- Chicago, IL13 ጥናቶች
- Atlanta, GA13 ጥናቶች
- St. Louis, MO13 ጥናቶች
- Cleveland, OH11 ጥናቶች
- Nashville, TN11 ጥናቶች
- Philadelphia, PA10 ጥናቶች
- Birmingham, AL10 ጥናቶች
- Los Angeles, CA10 ጥናቶች
- Mountain View, CA9 ጥናቶች
- Pittsburgh, PA9 ጥናቶች
- Baltimore, MD9 ጥናቶች
- Winston-Salem, NC9 ጥናቶች
- Jacksonville, FL9 ጥናቶች
- The Bronx, NY9 ጥናቶች
- Portland, OR8 ጥናቶች
- Buffalo, NY8 ጥናቶች
- New Haven, CT8 ጥናቶች
- Milwaukee, WI8 ጥናቶች
- Minneapolis, MN8 ጥናቶች
- Salt Lake City, UT8 ጥናቶች
- Memphis, TN7 ጥናቶች
- Clifton, NJ7 ጥናቶች
- Cedar Rapids, IA7 ጥናቶች
- Edison, NJ7 ጥናቶች
- Orange, CA7 ጥናቶች
- Kansas City, MO7 ጥናቶች
- Aurora, CO6 ጥናቶች
- San Francisco, CA6 ጥናቶች
- Rochester, NY6 ጥናቶች
- Queens, NY6 ጥናቶች
በክልል
- New Jersey13 ጥናቶች
- New Mexico4 ጥናቶች
- New York38 ጥናቶች
- North Carolina19 ጥናቶች
- North Dakota4 ጥናቶች
- Ohio22 ጥናቶች
- Oklahoma4 ጥናቶች
- Oregon10 ጥናቶች
- Pennsylvania17 ጥናቶች
- Rhode Island4 ጥናቶች
- South Carolina7 ጥናቶች
- Tennessee15 ጥናቶች
- Texas44 ጥናቶች
- Utah8 ጥናቶች
- Vermont3 ጥናቶች
- Virginia8 ጥናቶች
- Washington21 ጥናቶች
- West Virginia4 ጥናቶች
- Wisconsin11 ጥናቶች
- ሃዋይ3 ጥናቶች
- ሉዊዚያና5 ጥናቶች
- ሚሲሲፒ3 ጥናቶች
- ሚሺጋን8 ጥናቶች
- ሚኔሶታ13 ጥናቶች
- ሚዙሪ15 ጥናቶች
- ማሳቹሴትስ21 ጥናቶች
- ሜሪላንድ23 ጥናቶች
- ሜይን4 ጥናቶች
- ሞንታና3 ጥናቶች
- ኒብራስካ4 ጥናቶች
- ኒው ሃምፕሻየር5 ጥናቶች
- ኔቫዳ3 ጥናቶች
- አላባማ10 ጥናቶች
- አሪዞና9 ጥናቶች
- አርካንሳስ4 ጥናቶች
- አይዳሆ4 ጥናቶች
- አዮዋ7 ጥናቶች
- ኢሊኖይ16 ጥናቶች
- ኢንዲያና4 ጥናቶች
- ከንታኪ5 ጥናቶች
- ካሊፎርኒያ41 ጥናቶች
- ካንሳስ5 ጥናቶች
- ኮሎራዶ8 ጥናቶች
- ኮነቲከት10 ጥናቶች
- ዲስትሪክት ኦፍ ኮሎምቢያ4 ጥናቶች
- ጆርጂያ15 ጥናቶች
- ፍሎሪዳ31 ጥናቶች
በቅርብ ጊዜ የተዘመኑ ጥናቶች
Official study text (English)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ12 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06303193Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06577441Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06904066Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
1 Day – 99 Years · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07683104Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06484062Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ4 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT03173937The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07285044A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ12 እስከ 78 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03802695CHIP/CCUS Natural History Protocol
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT04102423MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05564390A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06548230Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06398457Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT03661307Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT05320198Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ4 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT01174108Natural History Study of GATA2 Deficiency and Related Disorders
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ2 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT01905826A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT07422480Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 1 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT03630991CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT04375631Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT04282187Collection of Tissue Samples for Cancer Research
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
2 Months · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT00900198Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06904482Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT03471260Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT03683433A Study of BGB-11417 in Participants With Myeloid Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT04771130ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።